TheraRadar
← Back
Data updated: Mar 29, 2026

SLATE RUN PHARMA

Infectious DiseaseCardiovascularRespiratory
Generics

SLATE RUN PHARMA is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Respiratory.

2006
Since
17
Drugs
-
Trials
158
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 36%
5 drugs
Cardiovascular 21%
3 drugs
Respiratory 14%
2 drugs
Dermatology 14%
2 drugs
Gastroenterology 14%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology, Respiratory
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Dermatology, Respiratory
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular